Formation Bio announces $600 million drug development fund
Formation Bio’s cofounder says the fund combines capital and AI-powered capabilities to acquire promising drugs and advance them through trials.
TLDR
Formation Bio cofounder Benjamin Liu announced the $600 million Drug Development Accelerator Fund. He says it will bring together capital, drug development expertise and AI-powered capabilities to acquire promising drugs and advance them through clinical trials. Liu argues that development, rather than discovery, is the biggest bottleneck to bringing new medicines to patients, and that faster AI-driven discovery is making it more pressing.
Combined views
205.4K
9 Sources, first seen ago



